Literature DB >> 18344036

[STEMI network Essen--results after 1 year].

Birgit Hailer1, Christoph K Naber, Bernd Koslowski, Thomas Budde, Rainer Jacksch, Georg Sabin, Silke Lange, Raimund Erbel.   

Abstract

The myocardial infarction network "Herzinfarktverbund Essen" was initiated on September 1, 2004 in order to establish a standardized strategy and therapy for patients with ST elevation myocardial infarction (STEMI) in the city of Essen. The primary goal is the immediate reopening of the infarcted vessel by direct transfer of the patient to a hospital with 24-h stand-by catheter laboratory. The first 1-year follow-up, completed on August 31, 2006, showed a low 1-year mortality rate (11.2%), whereby 7.6% of the patients died in hospital. There was a significant dependency of mortality on age, the prehospital stability of cardiovascular circulation, the amount of left ventricular damage, the TIMI flow after intervention, and the duration of interventional therapy ("puncture-to-balloon" time). The coronary status, anticoagulation therapy as well as diabetes mellitus were also dependent variables, whereas the type of stent showed no influence. The rate of restenosis was greater with bare-metal stents (BMS) compared to the use of drug-eluting stents (DES). There was a low rate of repeated STEMI or NSTEMI (non-ST elevation myocardial infarction; 1.8%, 1.7%). These first long-term data confirm the successful implementation of treatment guidelines for STEMI patients within a standardized strategy in an urban environment.

Entities:  

Mesh:

Year:  2008        PMID: 18344036     DOI: 10.1007/s00059-008-3091-7

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  3 in total

1.  In Reply.

Authors:  Christoph Hanefeld
Journal:  Dtsch Arztebl Int       Date:  2018-06-01       Impact factor: 5.594

2.  Primary angioplasty for any patient with ST-elevation myocardial infarction? Guideline-adherent feasibility and impact on mortality in a rural infarction network.

Authors:  Ralf Birkemeyer; Andreas Rillig; Annette Koch; Tomislav Miljak; Markus Kunze; Udo Meyerfeldt; Wolfgang Steffen; Martin Soballa; Carsten Ranke; Roland Prassler; Albert Benzing; Werner Jung
Journal:  Clin Res Cardiol       Date:  2010-07-06       Impact factor: 5.460

3.  Short term cost effectiveness of a regional myocardial infarction network.

Authors:  Ralf Birkemeyer; Anke Dauch; Alfred Müller; Manfred Beck; Henrik Schneider; Hueseyin Ince; Werner Jung; Steffen Wahler
Journal:  Health Econ Rev       Date:  2013-04-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.